The global Blood Group Typing Market was valued at USD 2.3 billion in 2025 and is projected to reach USD 5.6 billion by 2033, growing at a CAGR of 12.0% from 2026 to 2033. The market is expanding rapidly due to the increasing burden of chronic diseases, rising surgical procedures, organ transplantation, and growing awareness regarding transfusion safety. Blood group typing plays a critical role in ensuring compatibility between blood donors and recipients, minimizing transfusion-related complications, and improving patient outcomes. Continuous technological advancements in molecular diagnostics and automation are further strengthening market growth worldwide.

Key Highlights

• Market size reached USD 2.3 billion in 2025.
• Expected to reach USD 5.6 billion by 2033.
• CAGR of 12.0% from 2026 to 2033.
• North America accounted for 44.9% market share in 2025.
• Reagents & Consumables dominated the product segment with 71.5% share.
• PCR-based and Microarray-based techniques held 52.0% market share.
• Antibody Screening led the test type segment with 38.9% share.
• Asia Pacific is projected to be the fastest-growing regional market.

Overview

The blood group typing market continues to expand as healthcare providers prioritize transfusion safety and accurate blood compatibility testing. Increasing cases of anemia, cancer, sickle cell disease, thalassemia, trauma injuries, and complex surgical procedures are significantly increasing global blood transfusion requirements. Healthcare institutions are also investing in advanced molecular typing technologies, automated analyzers, and laboratory automation systems to improve testing accuracy, reduce turnaround time, and strengthen patient safety. Growing blood donation initiatives and stricter regulatory standards further support market expansion.

Download a free sample copy of the Blood Group Typing Market report to understand detailed coverage and inclusions in the final report

Market Trends

The market is witnessing a strong transition from conventional serological methods toward molecular blood typing technologies such as PCR-based genotyping and microarray analysis. Automation, artificial intelligence, and digital laboratory workflows are improving operational efficiency while minimizing human error. Point-of-care testing solutions and lab-on-chip technologies are also gaining popularity, particularly for emergency healthcare settings. Strategic investments in blood bank modernization and continuous innovation in diagnostic platforms are expected to shape the industry's future.

Market Dynamics

The growing need for safe blood transfusions remains the primary driver of the blood group typing market. Increasing incidences of chronic diseases, trauma cases, organ transplantation, pregnancy-related complications, and emergency surgeries require accurate ABO and Rh typing before transfusion. Rising blood donation programs worldwide further increase routine compatibility testing requirements.

At the same time, governments and healthcare organizations are strengthening transfusion safety regulations, encouraging hospitals and blood banks to adopt advanced automated blood typing systems. However, lengthy regulatory approval procedures and varying compliance requirements across countries may slow the commercialization of innovative products.

Analyst Perspective

The blood group typing market is rapidly evolving with technological innovation becoming a major competitive advantage. Companies are focusing on molecular diagnostics, automation, artificial intelligence, and high-throughput testing platforms to improve laboratory efficiency and diagnostic precision. Strategic collaborations, acquisitions, and product launches are enabling manufacturers to expand their global presence while addressing the increasing demand for reliable transfusion diagnostics. Emerging economies are expected to provide significant growth opportunities as healthcare infrastructure continues to improve.

Looking for more specific insights? Customize this report to suite your business needs

Segmentation

By Product: Reagents & Consumables dominated the market with a 71.5% revenue share in 2025 due to their recurring use in blood banks and diagnostic laboratories. Growing blood donation volumes and increasing adoption of automated testing systems continue to support segment growth. The Services segment is expected to witness strong growth as healthcare facilities increasingly outsource specialized blood typing and laboratory management services.

By Technique: PCR-based and Microarray-based techniques accounted for the largest market share of 52.0% in 2025 owing to their superior accuracy, sensitivity, and ability to detect rare blood group antigens. Meanwhile, assay-based techniques are expected to grow steadily due to their affordability, rapid turnaround time, and suitability for high-volume diagnostic laboratories.

By Test Type: The Antibody Screening segment held the largest share of 38.9% in 2025. Routine antibody screening before blood transfusions, surgeries, and pregnancy plays a vital role in preventing transfusion reactions. The HLA Typing segment is anticipated to register robust growth, supported by increasing organ transplantation procedures and advancements in molecular diagnostic technologies.

Regional Insights

North America remained the largest regional market with a 44.9% share in 2025, supported by advanced healthcare infrastructure, high adoption of molecular diagnostics, and strong regulatory standards. The United States continues to lead regional demand due to increasing surgical procedures, blood donations, and widespread use of automated blood typing systems.

Asia Pacific is expected to witness the fastest growth during the forecast period, driven by expanding healthcare infrastructure, increasing awareness of blood donation, rising chronic disease prevalence, and growing investments in diagnostic laboratories across countries such as China and India.

Explore Grand View Horizon to see global and regional level statistics related to the Blood Group Typing Market

Competitive Landscape

The blood group typing market is moderately fragmented, with leading companies competing through product innovation, automation, molecular diagnostics, strategic partnerships, and acquisitions. Companies continue investing in advanced blood typing technologies that improve laboratory efficiency, enhance transfusion safety, and expand their global customer base. Growing healthcare investments in emerging economies are creating additional opportunities for established manufacturers to strengthen their market presence.

Top Companies

• Grifols S.A.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Immucor, Inc.
• Novacyt Group
• Danaher Corporation
• Agena Bioscience, Inc.
• Ortho Clinical Diagnostics
• Quotient, Ltd.

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.